C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.
Klümper N, Saal J, Berner F, Lichtensteiger C, Wyss N, Heine A, Bauernfeind FG, Ellinger J, Brossart P, Diem S, Schmid S, Joerger M, Frueh M, Ritter M, Hölzel M, Flatz L, Bald T.
Klümper N, et al. Among authors: joerger m.
J Immunother Cancer. 2022 Mar;10(3):e004024. doi: 10.1136/jitc-2021-004024.
J Immunother Cancer. 2022.
PMID: 35292517
Free PMC article.